You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 33 No. 12, December 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reduced Growth Hormone Responses to Amphetamine in "Endogenous" Depressive Patients

Studies in Normal, "Reactive" and "Endogenous" Depressive, Schizophrenic, and Chronic Alcoholic Subjects

Gerhard Langer, MD; Gerhard Heinze, MD; Beatrix Reim, MD; Norbert Matussek, MD

Arch Gen Psychiatry. 1976;33(12):1471-1475.


Abstract

• Several pharmacological stimulation tests of the pituitaryhypothalamic system have been used to investigate psychiatric disorders. This study introduces amphetamine sulfate as a stimulus for human growth hormone (HGH) release in various psychiatric patients.

Peak HGH release after a single intravenous administration of amphetamine sulfate, 0.1 mg/kg, was significantly lower in nine "endogenous" depressives (P =.01) and significantly higher in seven "reactive" depressives (P <.05) as compared to normal subjects, whereas peak HGH release in eight schizophrenics and six chronic alcoholics did not differ significantly from that in normal subjects.

Considering the pharmacological properties of amphetamine and the present concepts of neural regulation of HGH, our findings are compatible with a current hypothesis that altered brain monoaminergic activities represent one biological correlate of depressive disorders.



Author Affiliations

From the Psychiatrische Klinik der Universitat Müncher, Munich, West Germany. Dr Langer is presently with the Albert Einstein College of Medicine, Bronx, NY.


Footnotes

Accepted for publication July 21, 1976.

Reprint requests to Psychiatrische Klinik der Universitat Müncher, Nussbaumstr 7, D-8000 Munich 2, West Germany (Dr Matussek).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Regional Cerebral Blood Flow Response to Oral Amphetamine Challenge in Healthy Volunteers
Devous et al.
JNM 2001;42:535-542.
ABSTRACT | FULL TEXT  

Growth Hormone Secretion in Prepubertal Children With Major Depression: I. Final Report on Response to Insulin-Induced Hypoglycemia During a Depressive Episode
Puig-Antich et al.
Arch Gen Psychiatry 1984;41:455-460.
ABSTRACT  

Growth Hormone Response to Dextroamphetamine in Depressed Patients and Normal Subjects
Halbreich et al.
Arch Gen Psychiatry 1982;39:189-192.
ABSTRACT  

Use of Antidepressant Drugs in Schizophrenia
Siris et al.
Arch Gen Psychiatry 1978;35:1368-1377.
ABSTRACT  

The Effect of Methylphenidate on Serum Growth Hormone: Influence of Antipsychotic Drugs and Diagnosis
Janowsky et al.
Arch Gen Psychiatry 1978;35:1384-1389.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.